Advisory Board and Editors Biochemistry
Dieter LD Deforce
Dieter Deforce PharmD, PhD, head of the Lab for Pharmaceutical Biotechnology at the Faculty of Pharmaceutical Sciences at the University of Gent, Belgium. He is chair of the Belgian Medicines Committee, he is member of the Scientific Advise Working Party of the EMA. He is a partner in NXT-GNT, a research consortium providing the research community next generation DNA-sequencing. He is also a partner in the Bioinformatics Institute Ghent From Nucleotides to Networks (BIG N2N) of the University Ghent. He is member of the board of directors of the VIB.
Research focuses around applying proteomics and genomics platforms (including Next Generation Sequencing) in the field of stem cell development, prenatal genetic diagnosis, (auto-)immunity and forensics.
Marc-André Delsuc
Marc-André Delsuc activity is mostly oriented toward the use and improvement of spectroscopies, in particular NMR and more recently FT-MS. This includes new experiment design, development of data processing methods, development of software programs. I have been deeply involved in field as diverse as protein structural analysis, protein-ligand screening, complex mixture analysis, quantum mechanic details of the NMR phenomenon, automatic data analysis, fractal dimension of proteins and polymers, etc.
Jeroen AA Demmers
Team leader Proteomics Center & Assistant Professor Erasmus University Medical Center Rotterdam
Education:
EUR Fellow, Erasmus University Medical Center
Postdoc, The Rockefeller University (Chait lab)
PhD, Utrecht University (Heck & Killian labs)
MSc (hons) Chemistry, Utrecht University
Robert J. Deschenes
Professor and Chair of the Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Fred Wright Professor of Cancer Biology
Elise Dumont
Dr. Elise Dumont is a professor at the Université Côte d'Azur, Institut de Chimie de Nice.
She is an expert in Computational Chemistry and Biochemistry, using methods ranging from quantum mechanics (mainly DFT) to classical mechanics.
Rudi H. Ettrich
Rudi received his prediploma in chemistry (Vordiplom) from Eberhard-Karls-University, Tuebingen, Germany, in 1993, his Master of sciences (Mgr.) in physical and macromolecular chemistry from Charles University, Prague, in 1998 and his PhD. in physical chemistry from Charles University, Prague, in 2002.
Since 2013 he is a full Professor (Prof.) in biophysics and currently acts as the President/CEO of Larkin University, Miami, FL and holds a faculty appointment at the College of Biomedical Sciences. He also holds community-based adjunct faculty positions at the Wertheim College of Medicine, Florida International University, Miami, FL, and the Department of Mathematics and Physics, Charles University, Czechia.
Prior to joining Larkin University Rudi was affiliated with the Czech Academy of Sciences, where he acted as director, group leader and senior researcher at the Center for Nanobiology and Structural Biology of the Institute of Microbiology in Nové Hrady, Academy of Sciences of the Czech Republic
Rudi's research is focused on the relationship between structure and function of proteins, dynamic changes related to functional processes on the level of proteins and the mutual interaction of cofactors and subunits in protein complexes. The research approach is very complex using various methods of protein research with a synthesis of theoretical and experimental methods.
Anthony C Faber
I currently serve as the co-leader of the developmental therapeutics program at VCU Massey Cancer Center, where I am also Associate Professor in the VCU Philips Institute. My laboratory focuses on finding new therapies in pediatric cancers.
Birthe Fahrenkrog
PhD in Cell Biology from the Biozentrum, University of Basel. Postdoctoral stays at the EMBL Heidelberg and the Biozentrum Basel. Group leader at the Biozentrum Basel (2003-2009), 2009-2020 Professor at the ULB, since August 2020 Senior Research Associate in the group of Prof. Dr. Roderick Lim at the Biozentrum, University of Basel. Research interest: nuclear pore complexes and nucleocytoplasmic transport; the role of nuclear pore proteins beyond nucleocytoplasmic transport. Editorial board member: Microbial Cell; Cells.
Faiza Farhan
Dr. Faiza Farhan earned a PhD in Clinical Science (specializing in stem cells) from Imperial College London in 2023.
Drawing on more than three years of editorial experience, Dr. Farhan seamlessly integrates her scientific knowledge with editorial prowess. Her extensive background in stem cell research fundamentally shapes her approach to scientific content editing. This powerful combination of rigorous academic training and practical editing expertise enables her to transform complex scientific concepts into clear, accessible information.
Anne Fernandez
Research Director of the Centre National de la Recherche Scientifique (CNRS); Lab leader of the Mammalian Cell Biology Unit at the Institute for Human Genetics (IGH) of the CNRS and University of Montpellier.
Principal research themes: Post-translational control of cell division cycle from quiescence to proliferation and differentiation of progenitor cells and multipotent stem cells from adult skeletal muscle.
B. Brett Finlay
The Peter Wall Distinguished Professor of the University of British Colombia. Recipient of several awards including the E.W.R. Steacie Prize, the CSM Fisher Scientific Award, an MRC Scientist, five Howard Hughes International Research Scholar Awards, a CIHR Distinguished Investigator, BC Biotech Innovation Award, the Michael Smith Health Research Prize, the IDSA Squibb award, the Jacob Biely Prize. Cofounder of Inimex Pharmaceuticals, Inc., and Director of the SARS Accelerated Vaccine Initiative
Mario Alberto Flores-Valdez
Dr. Mario Alberto Flores-Valdez is a Professor in the Medical and Pharmaceutical Biotechnology Unit, CIATEJ, A.C., Guadalajara, Jalisco, Mexico (2007-present). He is a member of the National System of Researchers (SNI), and a member of the Mexican Academy of Sciences. He was a Stanford University Medical Center postdoctoral fellow (2004-2007), where he received a Dean's Fellowship Award (2006) to conduct research on Tuberculosis. He worked in UNAM as Research Assistant for Prof. Jaime Mora (2004) and Prof. Emundo Calva (2003). He has received a Ph.D. in Biochemistry from UNAM (1999-2003), a M.Sc. in Molecular Biology and Genetic Engineering from UANL (1996-1999) and a B.Sc. from Universidad de Sonora (1991-1996) in Chemistry and Biology. He received fellowships from CONACYT for M.Sc. and Ph.D. studies and in M.Sc. and B.Sc. has received Diplomas as Best Student. He has expertise in Tuberculosis, particularly in developing recombinant BCG strains. He has been PI for 7 grants from 2008 to date, focused in studies about tuberculosis vaccine development and basic aspects of mycobacterial physiology.